Market Cap N/A
Revenue (ttm) 390.40M
Net Income (ttm) -11.93M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -3.06%
Debt to Equity Ratio N/A
Volume 2,821,941
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founde...

Industry: Health Information Services
Sector: Healthcare
Phone: 415 726 2206
Address:
455 Market Street, Suite 700, San Francisco, United States
Avocado_smash
Avocado_smash Jul. 2 at 4:16 AM
$HNGE Good
0 · Reply
Rolex53
Rolex53 Jul. 2 at 12:22 AM
$CLOV $HNGE 85 guys. $CLOV atleast 7 please.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jun. 30 at 9:55 PM
$HNGE Still bossing
0 · Reply
JFDI
JFDI Jun. 30 at 6:51 PM
@StaresAtCandles we really let that $HNGE get away.
1 · Reply
Vilhelm_gr8
Vilhelm_gr8 Jun. 30 at 1:26 PM
$HNGE I am selling now, after this for me super long rally. Good luck to all longs 💪
0 · Reply
Vilhelm_gr8
Vilhelm_gr8 Jun. 30 at 1:24 PM
$HNGE my bet is that p/s should be 10-30, when comparing to peers. 30 wont happen, maybe not even 10. Maybe some regulatory risks I cant understand. Time starts to show that there is a moat here. Free float super low. Maybe short squeeze after all? A litte fun that AI tools interpret the stock entirely differently now, as compared to 6-12 months ago. After all there is an idea to use the brain.
0 · Reply
SDSteelerFan
SDSteelerFan Jun. 29 at 11:48 PM
$HNGE volume is still wonderful, $90 is in our future!
1 · Reply
Vilhelm_gr8
Vilhelm_gr8 Jun. 29 at 5:58 PM
0 · Reply
ApeFeces
ApeFeces Jun. 29 at 5:43 PM
$HNGE really wish I bought more. I had a feeling it would hit low 30’s with my TA pointing to it, but I thought I’d have a longer time to accumulate there. Now I definitely wouldn’t want it to revisit those numbers or else it gets super bearish. This momentum has been a sneaker fr
0 · Reply
WhaleTracker_
WhaleTracker_ Jun. 29 at 5:02 PM
$HNGE What we’re seeing here is a newer IPO structure transitioning into price discovery while consistently pushing into fresh highs, which typically signals strong underlying demand rather than short-term speculative flow. The tape continues to show signs of steady accumulation rather than distribution, with price behavior staying constructive on pullbacks instead of breaking trend structure. From a positioning standpoint, this is the type of setup where the market gradually re-rates the story as fundamentals and growth expectations continue to compress into a higher valuation band. Strong margin profile, high-growth software exposure, and healthcare adjacency all contribute to the longer-duration narrative, but the key driver right now is pure trend acceptance. Not chasing extended moves, just respecting the strength of the underlying structure.
0 · Reply
Latest News on HNGE
Hinge Health price target raised to $65 from $55 at Baird

2026-06-17T10:21:48.000Z - 17 days ago

Hinge Health price target raised to $65 from $55 at Baird


Hinge Health price target raised to $76 from $65 at Canaccord

2026-06-15T10:42:46.000Z - 19 days ago

Hinge Health price target raised to $76 from $65 at Canaccord


Hinge Health price target raised to $90 from $75 at KeyBanc

2026-06-12T10:35:36.000Z - 22 days ago

Hinge Health price target raised to $90 from $75 at KeyBanc


Hinge Health price target raised to $85 from $79 at Truist

2026-06-11T13:40:33.000Z - 23 days ago

Hinge Health price target raised to $85 from $79 at Truist


Hinge Health price target raised to $76 from $63 at Needham

2026-06-11T11:23:50.000Z - 23 days ago

Hinge Health price target raised to $76 from $63 at Needham


Hinge Health price target raised to $70 from $62 at Barclays

2026-06-11T09:33:33.000Z - 23 days ago

Hinge Health price target raised to $70 from $62 at Barclays


Hinge Health Transcript: Investor Day 2026

Jun 10, 2026, 2:00 PM EDT - 24 days ago

Hinge Health Transcript: Investor Day 2026


Hinge Health Press release: FY 2026

Jun 10, 2026, 2:00 PM EDT - 24 days ago

Hinge Health Press release: FY 2026


Hinge Health Slides: FY 2026

Jun 10, 2026, 2:00 PM EDT - 24 days ago

Hinge Health Slides: FY 2026


Hinge Health adds orthopedic surgery to HingeSelect

2026-06-10T13:32:22.000Z - 24 days ago

Hinge Health adds orthopedic surgery to HingeSelect


Hinge Health price target raised to $79 from $67 at Stifel

2026-06-10T10:40:35.000Z - 24 days ago

Hinge Health price target raised to $79 from $67 at Stifel


Hinge Health hosts its first Investor Day and raises guidance

Jun 9, 2026, 4:05 PM EDT - 24 days ago

Hinge Health hosts its first Investor Day and raises guidance


Hinge Health price target raised to $65 from $63 at Canaccord

2026-06-04T10:55:09.000Z - 4 weeks ago

Hinge Health price target raised to $65 from $63 at Canaccord


Hinge Health Transcript: AGM 2026

Jun 3, 2026, 12:00 PM EDT - 4 weeks ago

Hinge Health Transcript: AGM 2026


Hinge Health price target raised to $62 from $52 at Barclays

2026-05-07T10:24:04.000Z - 2 months ago

Hinge Health price target raised to $62 from $52 at Barclays


Hinge Health Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Hinge Health Earnings Call Transcript: Q1 2026


Hinge Health Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Hinge Health Earnings release: Q1 2026


Hinge Health Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Hinge Health Slides: Q1 2026


Hinge Health Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Hinge Health Quarterly report: Q1 2026


Hinge Health launches comprehensive Migraine Care Program

Apr 29, 2026, 10:00 AM EDT - 2 months ago

Hinge Health launches comprehensive Migraine Care Program


Hinge Health Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Hinge Health Proxy statement: Proxy filing


Hinge Health Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Hinge Health Proxy statement: Proxy filing


Hinge Health appoints Tyler Sloat to its board of directors

Mar 17, 2026, 4:05 PM EDT - 3 months ago

Hinge Health appoints Tyler Sloat to its board of directors


Hinge Health Earnings Call Transcript: Q4 2025

Feb 10, 2026, 4:30 PM EST - 5 months ago

Hinge Health Earnings Call Transcript: Q4 2025


Hinge Health Annual report: Q4 2025

Feb 10, 2026, 4:30 PM EST - 5 months ago

Hinge Health Annual report: Q4 2025


Hinge Health Earnings release: Q4 2025

Feb 10, 2026, 4:30 PM EST - 5 months ago

Hinge Health Earnings release: Q4 2025


Hinge Health Slides: Q4 2025

Feb 10, 2026, 4:30 PM EST - 5 months ago

Hinge Health Slides: Q4 2025


Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%

Nov 24, 2025, 11:00 AM EST - 7 months ago

Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%


Hinge Health announces $250 million share repurchase program

Nov 12, 2025, 9:00 AM EST - 8 months ago

Hinge Health announces $250 million share repurchase program


Hinge Health Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Hinge Health Earnings Call Transcript: Q3 2025


Hinge Health Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Hinge Health Quarterly report: Q3 2025


Hinge Health Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Hinge Health Earnings release: Q3 2025


Hinge Health Slides: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Hinge Health Slides: Q3 2025


Hinge Health reports third quarter 2025 financial results

Nov 4, 2025, 4:05 PM EST - 8 months ago

Hinge Health reports third quarter 2025 financial results


Hinge Health unveils new AI-powered care tools

Oct 21, 2025, 11:00 AM EDT - 9 months ago

Hinge Health unveils new AI-powered care tools


Hinge Health CEO on Q2 earnings since IPO, AI usage and growth

Aug 5, 2025, 4:53 PM EDT - 11 months ago

Hinge Health CEO on Q2 earnings since IPO, AI usage and growth


Hinge Health Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Hinge Health Earnings Call Transcript: Q2 2025


Hinge Health Quarterly report: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Hinge Health Quarterly report: Q2 2025


Hinge Health Earnings release: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Hinge Health Earnings release: Q2 2025


Hinge Health Slides: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Hinge Health Slides: Q2 2025


Hinge Health Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 4:05 PM EDT - 11 months ago

Hinge Health Reports Second Quarter 2025 Financial Results


Hinge Health Goes Public, Raising $437M for Investors

May 22, 2025, 3:19 PM EDT - 1 year ago

Hinge Health Goes Public, Raising $437M for Investors


Hinge Health raises $437.3 million in US IPO

May 21, 2025, 7:15 PM EDT - 1 year ago

Hinge Health raises $437.3 million in US IPO


Hinge Health prices IPO at $32, the top end of expected range

May 21, 2025, 6:26 PM EDT - 1 year ago

Hinge Health prices IPO at $32, the top end of expected range


Hinge Health Announces Pricing of Initial Public Offering

May 21, 2025, 6:21 PM EDT - 1 year ago

Hinge Health Announces Pricing of Initial Public Offering


Hinge Health Registration statement: Registration Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


Hinge Health Aims to Raise $437 Million in IPO

May 13, 2025, 1:00 PM EDT - 1 year ago

Hinge Health Aims to Raise $437 Million in IPO


Hinge Health Announces Launch of Initial Public Offering

May 13, 2025, 8:40 AM EDT - 1 year ago

Hinge Health Announces Launch of Initial Public Offering


Hinge Health Registration statement: Registration Filing

May 13, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


Hinge Health targets $2.6 billion valuation in NYSE IPO

May 13, 2025, 6:46 AM EDT - 1 year ago

Hinge Health targets $2.6 billion valuation in NYSE IPO


Hinge Health Registration statement: Registration Filing

May 5, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


Avocado_smash
Avocado_smash Jul. 2 at 4:16 AM
$HNGE Good
0 · Reply
Rolex53
Rolex53 Jul. 2 at 12:22 AM
$CLOV $HNGE 85 guys. $CLOV atleast 7 please.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jun. 30 at 9:55 PM
$HNGE Still bossing
0 · Reply
JFDI
JFDI Jun. 30 at 6:51 PM
@StaresAtCandles we really let that $HNGE get away.
1 · Reply
Vilhelm_gr8
Vilhelm_gr8 Jun. 30 at 1:26 PM
$HNGE I am selling now, after this for me super long rally. Good luck to all longs 💪
0 · Reply
Vilhelm_gr8
Vilhelm_gr8 Jun. 30 at 1:24 PM
$HNGE my bet is that p/s should be 10-30, when comparing to peers. 30 wont happen, maybe not even 10. Maybe some regulatory risks I cant understand. Time starts to show that there is a moat here. Free float super low. Maybe short squeeze after all? A litte fun that AI tools interpret the stock entirely differently now, as compared to 6-12 months ago. After all there is an idea to use the brain.
0 · Reply
SDSteelerFan
SDSteelerFan Jun. 29 at 11:48 PM
$HNGE volume is still wonderful, $90 is in our future!
1 · Reply
Vilhelm_gr8
Vilhelm_gr8 Jun. 29 at 5:58 PM
0 · Reply
ApeFeces
ApeFeces Jun. 29 at 5:43 PM
$HNGE really wish I bought more. I had a feeling it would hit low 30’s with my TA pointing to it, but I thought I’d have a longer time to accumulate there. Now I definitely wouldn’t want it to revisit those numbers or else it gets super bearish. This momentum has been a sneaker fr
0 · Reply
WhaleTracker_
WhaleTracker_ Jun. 29 at 5:02 PM
$HNGE What we’re seeing here is a newer IPO structure transitioning into price discovery while consistently pushing into fresh highs, which typically signals strong underlying demand rather than short-term speculative flow. The tape continues to show signs of steady accumulation rather than distribution, with price behavior staying constructive on pullbacks instead of breaking trend structure. From a positioning standpoint, this is the type of setup where the market gradually re-rates the story as fundamentals and growth expectations continue to compress into a higher valuation band. Strong margin profile, high-growth software exposure, and healthcare adjacency all contribute to the longer-duration narrative, but the key driver right now is pure trend acceptance. Not chasing extended moves, just respecting the strength of the underlying structure.
0 · Reply
JFDI
JFDI Jun. 29 at 4:56 PM
wow, $HNGE really taking off.
0 · Reply
jpcalm68
jpcalm68 Jun. 29 at 3:36 PM
$HNGE This has done very well lately. Sometimes it takes a great company a while to find its footing after the IPO.
0 · Reply
Merlintrader
Merlintrader Jun. 28 at 9:21 PM
0 · Reply
SmartMoneyRadar
SmartMoneyRadar Jun. 27 at 11:11 PM
Russell rebalance continues to show up clearly in volume data. A few names saw meaningful spikes versus their 20D averages: $BE 52.7M vs 11.0M avg $CRDO 38.6M vs 11.8M avg $HNGE 9.0M vs 2.5M avg $MU 86.4M vs 58.2M avg This kind of flow is usually mechanical rather than narrative-driven. Index adjustments, forced rebalancing, and liquidity shifts tend to temporarily distort price action. Worth watching how these names behave once passive flows normalize. Next alert coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.
2 · Reply
Merlintrader
Merlintrader Jun. 27 at 8:55 PM
$ONDS Russell 2026 Final Rebalance Radar: Best Post-Upgrade Stocks to Watch by Sector $KNSA $FCEL $HNGE https://www.merlintrader.com/russell-2026-final-rebalance-radar-best-post-upgrade-stocks-to-watch-by-sector/
0 · Reply
Rolex53
Rolex53 Jun. 27 at 1:45 AM
$CLOV Still Clover management needs to focus on Operating expenses. Also if one likes $HNGE above 70 then $CLOV is an easy buy for them.
0 · Reply
WallStJesus
WallStJesus Jun. 26 at 6:56 PM
$HNGE REPEAT BUYING..
0 · Reply
Avocado_smash
Avocado_smash Jun. 26 at 2:06 PM
$HNGE Crazy
0 · Reply
cokespo0n
cokespo0n Jun. 25 at 12:41 PM
$HNGE this thing is a monster, 90 eoy $WEN
0 · Reply
victorgn
victorgn Jun. 24 at 7:01 PM
Rank Ticker Entry Quality Upside Risk Level Best For 1 $APP ✅✅ Excellent +23.3% Low Best risk/reward 2 $CRDO ✅ Good +52.4% Medium Momentum continuation 3 $DELL ⚠️ Decent +27.6% Medium-High Momentum chasing 4 $BE ⚠️ Decent +23.5% Medium Momentum with room 5 $HNGE ❌ Poor entry +86.9% High Aggressive only
0 · Reply
MorganHoratio
MorganHoratio Jun. 23 at 6:09 PM
Your timeline will do its best to spread fear today. Your job is to find relative strength. Names standing out so far: $DAVE $OSCR $OUST $DDOG $HNGE When macro timelines aggressively broadcast fear, the ultimate mandate for smart money is identifying Relative Strength. This specific shortlist captures pristine value-growth capital insulating itself against broader market de-risking. Fintech disruption champion $DAVE (fresh off an elite earnings surprise and multi-quarter highs) and digital health pioneer $HNGE (surpassing structural breakeven inflection points) are absorbing sell-offs beautifully, maintaining pristine technical posture above historical volume nodes. $OUST, SaaS blueprint $DDOG, and insurance tech $OSCR are heavily attracting institutional inflows. Their clear right-side trend resilience indicates massive structural outperformance. Which of these anti-gravity names are you putting on top of your watchlist today?
0 · Reply
__LucidDreamer__
__LucidDreamer__ Jun. 18 at 6:23 PM
$HNGE out with a nice/quick gain. again.
0 · Reply